Braskem S.A.
NYSE:BAKChemicals
-$0.40 today
- Market cap
- $343.37M
- Beta
- 0.67
- P/E (TTM)
- -0.7
- EPS (TTM)
- -$11.45
Volume 3.32M
Average 2.97M
BAK Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Braskem S.A.NYSE: BAK
Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026
Cost of revenue declines year over year
Q1 FY2026 cost of revenue of R$14.39B fell 20.7% year over year, behind the -10.2% change in trailing-twelve-month cost of revenue. Sequentially, it fell 13.6% from the prior quarter. Over 3 fiscal years it compounded at -7.3% a year.
Context
- Cost of revenue amounted to 97.8% of revenue in FY2025, up 5.5 pp from a year earlier.
- Cost of revenue increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -20.7% toward the trailing-twelve-month pace of -10.2%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
BRL · from the income statement
- Latest · FY2025
- 67.8B BRL
- Year-over-year change
- -5.1%
- 4-year CAGR
- -2.0%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 67.8B | -5.1% |
| FY2024 | 2024-12-31 | 71.41B | +5.7% |
| FY2023 | 2023-12-31 | 67.55B | -20.7% |
| FY2022 | 2022-12-31 | 85.16B | +15.8% |
| FY2021 | 2021-12-31 | 73.57B | — |
Cost of Revenue vs competitors
How BAK compares with its peers on the latest reported figures
- Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -10.2% is the 10th highest of 11, against a peer median of +16.5%.
- Cost of revenue amounts to 98.0% of revenue for BAK, versus a peer median of 80.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | R$65.4B BRL | -10.2% | -7.3% | 98.0% | |
| LTM Mar 2026 | $2.08B USD | +7.2% | -4.2% | 88.9% | |
| LTM Mar 2026 | $1.34B USD | -7.2% | -5.4% | 93.9% | |
| LTM Mar 2026 | $847.22M USD | +18.0% | -12.3% | 68.6% | |
| LTM Mar 2026 | $639.27M USD | +25.9% | -1.7% | 78.0% | |
| LTM Apr 2026 | $547.76M USD | -0.1% | -11.6% | 83.5% | |
| LTM Mar 2026 | $480.22M USD | +18.1% | -2.9% | 74.7% | |
| LTM Mar 2026 | $180.98M USD | +35.1% | +16.6% | 76.7% | |
| LTM Mar 2026 | $22.18M USD | +704.4% | — | 82.4% | |
CNLCollective Mining Ltd. | LTM Mar 2026 | $170.76K USD | -47.3% | +122.9% | — |
| LTM Mar 2026 | CA$125.96K CAD | +15.0% | +1.3% | — | |
| Peer median (excluding BAK) | — | +16.5% | -2.9% | 80.2% | |
Competitors are the stored peer set for BAK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 105.63B | 96.52B | 70.57B | 77.41B | 69.33B |
| Cost of Revenue | 73.57B | 85.16B | 67.55B | 71.41B | 67.8B |
| Gross Profit | 32.06B | 11.36B | 3.02B | 6B | 1.53B |
| Gross Margin | 30.3% | 11.8% | 4.3% | 7.7% | 2.2% |
| Research & Development | 297M | 374M | 383M | 463M | 450.96M |
| Selling, General & Admin | 4.58B | 4.87B | 4.39B | 4.63B | 4.68B |
| Operating Expenses | 4.88B | 5.25B | 4.77B | 4.99B | 5.48B |
| Depreciation & Amortization | 4.18B | 4.73B | 5.21B | 3.75B | 4.58B |
| EBITDA | 25.33B | 8.11B | 3.26B | 2.7B | 631.35M |
| EBITDA Margin | 24.0% | 8.4% | 4.6% | 3.5% | 0.9% |
| Operating Income | 27.18B | 6.11B | (1.75B) | 1.01B | (3.95B) |
| Operating Margin | 25.7% | 6.3% | -2.5% | 1.3% | -5.7% |
| Interest Income | 440M | 1.05B | 873M | 1.26B | 711.74M |
| Interest Expense | 3.19B | 3.33B | 4.78B | 5.44B | 5.82B |
| Other Income / Expenses | (9.22B) | (6.07B) | (4.44B) | (18.75B) | 1.16B |
| Income Before Tax | 17.96B | 47M | (6.19B) | (17.73B) | (2.79B) |
| Pre-Tax Margin | 17.0% | 0.0% | -8.8% | -22.9% | -4.0% |
| Income Tax Expense | 4B | 868M | (1.3B) | (5.68B) | 7.96B |
| Net Income | 13.99B | (336M) | (4.58B) | (11.32B) | (9.69B) |
| Net Margin | 13.2% | -0.3% | -6.5% | -14.6% | -14.0% |
| EPS (Basic) | 35.12 | (2.06) | (11.50) | (28.40) | (24.32) |
| EPS (Diluted) | 35.08 | (2.06) | (11.50) | (28.40) | (24.32) |
| Weighted Avg Shares | 398.11M | 398.24M | 398.35M | 398.6M | 398.6M |
| Weighted Avg Shares (Diluted) | 398.61M | 398.6M | 398.35M | 398.6M | 398.6M |
Braskem S.A.
NYSE:BAK
Intrinsic Alpha fair value
Locked
Current Price
$0.86
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.